- Contractors
- Cygnos Biotech, LLC
Cygnos Biotech, LLC
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Cygnos Biotech has 2 federal contracts of $100,000 or more active since October 2023, with $1.6M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 2 since FY2024$1,601,657 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Department of the Army$1.6M on 2 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- PXYDY5CQJDM3Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2025 | $204,493 |
| FY2026 | $1,397,164 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| The Purpose of This Small Business Innovation Research (Sbir) Phase II Contract Is to Show Efficacy of Anti-Viral Treatment With the Pvx Therapeutic.Department of the Army · W911SR26CA003 | $1,397,164 | Aug 1, 2027in 8 months | FL |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Department of the Army2 contracts | $1,601,657 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts | $1,601,657 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Florida2 contracts | $1,601,657 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Department of the Army: see the list.
Get new notices like Cygnos Biotech's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy